The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Clinical trial NCT00411996 · COMPLETED

Trial details

NCT number: NCT00411996
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV Infections Tuberculosis

Start date: 2006-12-01
Primary completion: 2008-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.